TY - JOUR
T1 - Hydrochlorothiazide therapy in nephrolithiasis effect on the urinary activity product and formation product of brushite
AU - Pak, Charles Y C
PY - 1973
Y1 - 1973
N2 - The effect of hydrochlorothiazide on the formation of renal stones containing calcium was evaluated by the quantitative assessment of the propensity of urine for the nucleation of brushite (nidus of calcium stones). In 6 patients with renal stones, the urinary activity product ratio (APR) and the formation product ratio (FPR) of brushite were measured before, during, and following treatment with hydrochlorothiazide (50 mg twice a day orally) for from 5 days to 1 month. The urinary APR (the state of saturation with respect to brushite) decreased in the majority of cases primarily as the result of a fall in urinary calcium. The urinary FPR (lowest state of supersaturation at which nucleation is initiated) usually increased, probably as a result of a rise in urinary pyrophosphate. Both changes reduced the propensity for the formation of the nidus of brushite, and may therefore account for the improvement reported after thiazide therapy in nephrolithiasis.
AB - The effect of hydrochlorothiazide on the formation of renal stones containing calcium was evaluated by the quantitative assessment of the propensity of urine for the nucleation of brushite (nidus of calcium stones). In 6 patients with renal stones, the urinary activity product ratio (APR) and the formation product ratio (FPR) of brushite were measured before, during, and following treatment with hydrochlorothiazide (50 mg twice a day orally) for from 5 days to 1 month. The urinary APR (the state of saturation with respect to brushite) decreased in the majority of cases primarily as the result of a fall in urinary calcium. The urinary FPR (lowest state of supersaturation at which nucleation is initiated) usually increased, probably as a result of a rise in urinary pyrophosphate. Both changes reduced the propensity for the formation of the nidus of brushite, and may therefore account for the improvement reported after thiazide therapy in nephrolithiasis.
UR - http://www.scopus.com/inward/record.url?scp=0015594283&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0015594283&partnerID=8YFLogxK
U2 - 10.1002/cpt1973142209
DO - 10.1002/cpt1973142209
M3 - Article
C2 - 4348641
AN - SCOPUS:0015594283
SN - 0009-9236
VL - 14
SP - 209
EP - 217
JO - Clinical pharmacology and therapeutics
JF - Clinical pharmacology and therapeutics
IS - 2
ER -